Atlas Trials

Study to Evaluate the Effect of CIN-107 on the Pharmacokinetics of the MATE Substrate, Metformin, in Healthy Subjects

Clinical trial NCT05526690 · COMPLETED

Trial details

NCT number
NCT05526690
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypertension
Start date
2020-10-28
Primary completion
2020-12-12
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.